Anticoagulation during continuous renal replacement therapy

R L Mehta1

  • 1Department of Medicine, University of California, San Diego.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|October 1, 1994
PubMed

Insights

Anticoagulation is crucial for continuous renal replacement therapy (CRRT) filter function. Selecting the right anticoagulant considers patient factors, access, and membrane type to prevent complications.

Area of Science:

  • Nephrology
  • Critical Care Medicine

Background:

  • Anticoagulation is vital for the function and longevity of filters used in continuous venovenous hemofiltration (CAVH) or CAVHD and is a critical challenge in continuous renal replacement therapy (CRRT).
  • Multiple anticoagulation strategies are available, allowing for selection based on patient-specific characteristics, anticoagulant availability, and institutional expertise.

Purpose of the Study:

  • To review and discuss the factors influencing the choice of anticoagulation in CRRT.
  • To highlight the importance of careful selection and monitoring of anticoagulation to prevent complications.

Main Methods:

  • Review of current anticoagulation options and influencing factors in CRRT.
  • Discussion of patient-specific considerations for anticoagulant selection.

Main Results:

  • Anticoagulant choice depends on access site, pump use, membrane characteristics, ultrafiltration enhancements (e.g., predilution), and patient's clinical status and coagulation profile.
  • Continuous anticoagulation in CRRT requires longer duration and thus more meticulous management than in intermittent hemodialysis.

Conclusions:

  • Careful selection and vigilant monitoring of anticoagulation are essential for successful CRRT and prevention of filter-related complications.
  • Tailoring anticoagulation strategies to individual patient needs and treatment parameters optimizes filter performance and patient safety.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...